| 2025-11-19 | Herriott James | SVP, General Counsel & Sec | Sell | 1,000 | $70.00 | $70,000.00 | -7.9% | → |
| 2025-11-19 | ORVILLE JACOB A | EVP, GM, Screening | Sell | 5,000 | $75.00 | $375,000.00 | -17.7% | → |
| 2025-11-04 | Baranick Brian | EVP, GM, Precision Oncology | Sell | 2,858 | $70.08 | $200,288.64 | -11.3% | → |
| 2025-11-04 | Herriott James | SVP, General Counsel & Sec | Sell | 1,500 | $70.08 | $105,120.00 | -10.6% | → |
| 2025-10-24 | Zanotti Katherine S | - | Sell | 12,000 | $65.00 | $780,000.00 | -16.5% | → |
| 2025-10-09 | Doyle James Edward | - | Sell | 2,000 | $60.00 | $120,000.00 | -3.3% | → |
| 2025-10-09 | Herriott James | SVP, General Counsel & Sec | Sell | 1,500 | $60.00 | $90,000.00 | -9.6% | → |
| 2025-08-13 | Doyle James Edward | - | Sell | 1,485 | $42.02 | $62,399.70 | -2.4% | → |
| 2025-06-13 | Zanotti Katherine S | - | Sell | 3,207 | $53.20 | $170,612.40 | -4.2% | → |
| 2024-11-13 | Conroy Kevin T | President and CEO | Buy | 19,500 | $51.35 | $1,001,325.00 | +1.8% | → |
| 2024-10-08 | Baranick Brian | EVP, GM, Precision Oncology | Sell | 929 | $70.00 | $65,030.00 | -6.8% | → |
| 2024-09-18 | Baranick Brian | EVP, GM, Precision Oncology | Sell | 929 | $70.00 | $65,030.00 | -6.4% | → |
| 2024-05-01 | Elliott Jeffrey Thomas | Chief Financial Officer | Sell | 136 | $60.15 | $8,180.40 | -1.1% | → |
| 2024-05-01 | Herriott James | SVP, General Counsel & Sec | Sell | 30 | $60.15 | $1,804.50 | -0.3% | → |
| 2024-05-01 | Cunningham Everett | Chief Commercial Officer | Sell | 136 | $60.15 | $8,180.40 | -0.3% | → |
| 2024-05-01 | Baranick Brian | EVP, GM., Precision Oncology | Sell | 110 | $60.15 | $6,616.50 | -0.8% | → |
| 2024-05-01 | Conroy Kevin T | President and CEO | Sell | 1,155 | $60.15 | $69,473.25 | - | → |
| 2024-05-01 | ORVILLE JACOB A | General Manager, Screening | Sell | 102 | $60.15 | $6,135.30 | -0.7% | → |
| 2024-05-01 | COWARD D SCOTT | - | Sell | 67 | $60.15 | $4,030.05 | -0.1% | → |
| 2024-05-01 | Condella Sarah | EVP, Human Resources | Sell | 102 | $60.15 | $6,135.30 | -0.1% | → |
| 2024-04-02 | Baranick Brian | EVP, GM., Precision Oncology | Sell | 924 | $79.43 | $73,393.32 | -6.6% | → |
| 2024-04-01 | Condella Sarah | EVP, Human Resources | Sell | 2,000 | $70.00 | $140,000.00 | -2.7% | → |
| 2024-03-28 | Condella Sarah | EVP, Human Resources | Sell | 2,000 | $70.00 | $140,000.00 | -2.6% | → |
| 2024-03-01 | Doyle James Edward | Director | Sell | 2,000 | $57.50 | $115,000.00 | -3.8% | → |
| 2024-03-01 | LEVANGIE DANIEL J | Director | Sell | 5,000 | $57.50 | $287,500.00 | -17.9% | → |
| 2024-03-01 | Conroy Kevin T | President and CEO | Sale+OE | 8,271 | $59.32 | $490,635.72 | -0.6% | → |
| 2024-03-01 | Cunningham Everett | Chief Commercial Officer | Sale+OE | 2,412 | $59.32 | $143,079.84 | -5.0% | → |
| 2024-03-01 | Herriott James | General Counsel | Sale+OE | 862 | $59.32 | $51,133.84 | -8.6% | → |
| 2024-03-01 | Elliott Jeffrey Thomas | Chief Financial Officer | Sale+OE | 2,412 | $59.32 | $143,079.84 | -18.1% | → |
| 2024-03-01 | Condella Sarah | EVP, Human Resources | Sale+OE | 1,724 | $59.32 | $102,267.68 | -2.2% | → |
| 2024-03-01 | Baranick Brian | Gen. Mgr., Precision Oncology | Sale+OE | 2,323 | $59.32 | $137,800.36 | -14.1% | → |
| 2024-03-01 | ORVILLE JACOB A | General Manager, Screening | Sale+OE | 2,154 | $59.32 | $127,775.28 | -13.1% | → |
| 2024-02-27 | Herriott James | General Counsel | Sale+OE | 784 | $56.89 | $44,601.76 | -8.8% | → |
| 2024-02-27 | ORVILLE JACOB A | General Manager, Screening | Sale+OE | 1,879 | $56.89 | $106,896.31 | -13.8% | → |
| 2024-02-27 | Baranick Brian | Gen. Mgr., Precision Oncology | Sale+OE | 2,027 | $56.89 | $115,316.03 | -14.8% | → |
| 2024-02-27 | Condella Sarah | EVP, Human Resources | Sale+OE | 1,880 | $56.89 | $106,953.20 | -2.5% | → |
| 2024-02-27 | Conroy Kevin T | President and CEO | Sale+OE | 6,263 | $56.89 | $356,302.07 | -0.5% | → |
| 2024-02-27 | Elliott Jeffrey Thomas | Chief Financial Officer | Sale+OE | 2,710 | $56.89 | $154,171.90 | -25.2% | → |
| 2024-02-27 | Cunningham Everett | Chief Commercial Officer | Sale+OE | 3,648 | $56.89 | $207,534.72 | -7.8% | → |
| 2024-02-23 | Condella Sarah | EVP, Human Resources | Sell | 1,021 | $59.72 | $60,974.12 | -1.4% | → |
| 2024-02-22 | COWARD D SCOTT | Director | Sell | 663 | $59.78 | $39,634.14 | -1.5% | → |
| 2024-02-22 | ORVILLE JACOB A | General Manager, Screening | Sell | 1,013 | $59.78 | $60,557.14 | -9.5% | → |
| 2024-02-22 | Baranick Brian | Gen. Mgr., Precision Oncology | Sell | 1,093 | $59.78 | $65,339.54 | -10.1% | → |
| 2024-02-22 | Condella Sarah | EVP, Human Resources | Sell | 1,013 | $59.78 | $60,557.14 | -1.4% | → |
| 2024-02-22 | Conroy Kevin T | President and CEO | Sell | 11,565 | $59.78 | $691,355.70 | -0.9% | → |
| 2024-02-22 | Cunningham Everett | Chief Commercial Officer | Sell | 1,350 | $59.78 | $80,703.00 | -3.3% | → |
| 2024-02-22 | Elliott Jeffrey Thomas | Chief Financial Officer | Sell | 1,351 | $59.78 | $80,762.78 | -21.1% | → |
| 2024-02-22 | Herriott James | General Counsel | Sell | 291 | $59.78 | $17,395.98 | -3.9% | → |
| 2024-02-21 | Elliott Jeffrey Thomas | Chief Financial Officer | Sale+OE | 1,493 | $61.50 | $91,819.50 | -28.7% | → |
| 2024-02-21 | Herriott James | General Counsel | Sale+OE | 415 | $61.50 | $25,522.50 | -5.6% | → |